BerGenBio ASA (BRRGF)
USD 2.31
(-7.6%)
USD 2.31
(-7.6%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 192.17 Million NOK | -64.14% |
| 2022 | 32.17 Million USD | -13.19% |
| 2021 | 37.05 Million USD | 79.24% |
| 2020 | 20.67 Million USD | 7.66% |
| 2019 | 19.2 Million USD | 11.43% |
| 2018 | 17.23 Million USD | -23.48% |
| 2017 | 22.52 Million USD | 40.58% |
| 2016 | 16.02 Million USD | 95.07% |
| 2015 | 8.21 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.19 Million USD | -45.92% |
| 2024 Q2 | 4.84 Million USD | 118.03% |
| 2023 Q1 | 7.02 Million USD | -15.98% |
| 2023 Q3 | 2.72 Million USD | -40.33% |
| 2023 Q4 | 3.21 Million USD | 18.06% |
| 2023 Q2 | 4.56 Million USD | -34.99% |
| 2023 FY | 11.53 Million USD | -64.14% |
| 2022 Q2 | 9.01 Million USD | -0.35% |
| 2022 FY | 32.17 Million USD | -13.19% |
| 2022 Q4 | 8.36 Million USD | 43.29% |
| 2022 Q3 | 5.83 Million USD | -35.26% |
| 2022 Q1 | 9.04 Million USD | 2.75% |
| 2021 Q2 | 10.75 Million USD | 9.74% |
| 2021 FY | 37.05 Million USD | 79.24% |
| 2021 Q1 | 9.8 Million USD | 0.0% |
| 2021 Q4 | 8.8 Million USD | 6.24% |
| 2021 Q3 | 8.28 Million USD | -22.97% |
| 2020 FY | 20.67 Million USD | 7.66% |
| 2019 FY | 19.2 Million USD | 11.43% |
| 2018 FY | 17.23 Million USD | -23.48% |
| 2017 FY | 22.52 Million USD | 40.58% |
| 2016 FY | 16.02 Million USD | 95.07% |
| 2015 FY | 8.21 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bioxytran, Inc. | 3.82 Million USD | -4930.513% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -121.436% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -73325.262% |
| SQZ Biotechnologies Company | 85.61 Million USD | -124.451% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -6489.764% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -550.266% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -415.822% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -12695.334% |
| Marizyme, Inc. | 19.23 Million USD | -898.829% |
| Genus plc | 147.7 Million USD | -30.11% |
| Pharming Group N.V. | 225.49 Million USD | 14.776% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -9280.218% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -14224.752% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -2204.509% |
| ContraFect Corporation | 56.88 Million USD | -237.803% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -12895.621% |
| IMV Inc. | 37.7 Million USD | -409.618% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -6787.04% |
| ONE Bio Corp. | 6.44 Million USD | -2882.25% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -123.6% |
| Mesoblast Limited | 5.9 Million USD | -3156.066% |
| MultiCell Technologies, Inc. | 567.42 USD | -33867758.024% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -677.556% |
| Genscript Biotech Corporation | 825.34 Million USD | 76.716% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -49230.024% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -7213.849% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -3807.613% |
| Biomind Labs Inc. | 994.18 Thousand USD | -19229.761% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -10820.918% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -2760.562% |
| Skye Bioscience, Inc. | 13.54 Million USD | -1318.507% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -10207.664% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -2088.95% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 768792.0% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -4258.977% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -3711.411% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -1100.313% |
| Accustem Sciences Inc. | 3.74 Million USD | -5029.512% |
| EV Biologics, Inc. | 531.96 Thousand USD | -36025.325% |
| Q BioMed Inc. | 3.43 Million USD | -5491.906% |
| GB Sciences, Inc. | 1.42 Million USD | -13428.461% |
| Alpha Cognition Inc. | 9.7 Million USD | -1880.022% |
| CSL Limited | 3.44 Billion USD | 94.428% |
| Agentix Corp. | 1.37 Million USD | -13909.27% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -93.469% |
| Enzolytics Inc. | 2.17 Million USD | -8717.269% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 12.71 Million USD | -1411.745% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -5163.994% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -10372.101% |
| argenx SE | 1.53 Billion USD | 87.469% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -234.563% |
| HST Global, Inc. | 140.9 Thousand USD | -136282.862% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -18307.375% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -16983.411% |
| Halberd Corporation | 74.84 Thousand USD | -256671.599% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -7890.781% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -5543.882% |
| Zenith Capital Corp. | 8.94 Million USD | -2048.865% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -12067.815% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -7726.81% |
| AVAX Technologies, Inc. | 7.31 Million USD | -2528.811% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -111948.347% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -9904.29% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -1103011.188% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.46 Million USD | -7690.499% |
| Helix BioMedix, Inc. | 1.97 Million USD | -9644.913% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -1668.409% |
| Kadimastem Ltd | 2.41 Million USD | -7873.613% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | -736.451% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -105789.192% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -14290.335% |
| LadRx Corporation | 3.81 Million USD | -4941.541% |
| Cell Source, Inc. | 4.32 Million USD | -4342.951% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -46153.361% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -20708.979% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -20708.979% |
| Affymax, Inc. | 39.38 Million USD | -387.922% |
| Mobile Lads Corp. | 554.54 Thousand USD | -34554.113% |
| Itoco Inc. | 919.14 Thousand USD | -20807.846% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -4434.078% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -17073.637% |
| International Stem Cell Corporation | 5.27 Million USD | -3545.855% |
| CytoDyn Inc. | 18.05 Million USD | -964.199% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -763430.534% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -87220.405% |
| Qrons Inc. | 643.67 Thousand USD | -29755.502% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -13435.292% |
| SYBLEU INC | 160.87 Thousand USD | -119354.114% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -8518.091% |
| Rebus Holdings, Inc. | 664 Thousand USD | -28841.717% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -10480.349% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -364956.419% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -944564.012% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -429.899% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -11777.194% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -26016.317% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -6077.21% |
| Neutra Corp. | 243.82 Thousand USD | -78717.247% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -1000.836% |
| PureTech Health plc | 144.59 Million USD | -32.902% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -837.892% |
| IXICO plc | 4.7 Million USD | -3982.707% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -2084.529% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -63.207% |
| CSL Limited | 3.89 Billion USD | 95.064% |
| Cellectis S.A. | 97.32 Million USD | -97.465% |